The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Boston Scientific shares fell by 12.53% on May 27 after the company reiterated its lackluster full-year organic growth guidance. This decline reflects investor concerns about the company's future performance.